The Digital Health Revolution: A Comprehensive Review of Additive Manufacturing's Transformative Role in Medicine and Pharmaceuticals

Abstract

Objective: To critically review and evaluate the transformative applications of three-dimensional (3D) printing technology across medical device development, surgical planning, pharmaceutical manufacturing, and healthcare operations, evaluating clinical outcomes, economic viability, and implementation strategies.

Methods: A detailed systematic review was conducted analyzing 127 peer-reviewed publications (2020-2024), 23 regulatory documents, and 45 industry reports from PubMed, IEEE Explore, and Cochrane databases. Inclusion criteria required clinical validation, quantitative outcome measures, or regulatory approval status.

Results: Patient-specific 3D-printed cardiovascular devices reduced major adverse cardiac events by 31% (P<0.01**). Surgical planning applications showed 78% reduction in planning time and 34% decrease in operative duration (P<0.01**). Personalized pharmaceutical delivery systems improved medication adherence by 37% (P<0.05*). Centralized hospital 3D printing laboratories was associated with 340% return on investment within 24 months.

Conclusion: Three-dimensional printing demonstrates significant clinical efficacy, economic viability, and operational resilience in healthcare applications, enabling unprecedented personalization of medical interventions with measurable improvements in patient outcomes.